首页> 美国政府科技报告 >NIAID Biodefense Research Agenda for Category B and C Priority Pathogens;Progress rept
【24h】

NIAID Biodefense Research Agenda for Category B and C Priority Pathogens;Progress rept

机译:NIaID生物防御研究议程B类和C类优先病原体;进展情况

获取原文

摘要

The nation's ability to detect and counter bioterrorism depends largely on information generated through biomedical research on pathogenic microbes and the immune response to these microbes. A small amount of biodefense research had been conducted for years by civilian agencies such as the National Institutes of Health (NIH). It was the anthrax attacks of 2001, however, that revealed significant gaps in the nation's overall preparedness against potential agents of bioterrorism.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号